Cargando…
Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study
SIMPLE SUMMARY: Acute promyelocytic leukemia (APL) is a rare and aggressive subtype of acute myeloid leukemia (AML). Since the introduction of all-trans-retinoic acid (ATRA) in APL management, the survival rate has increased substantially. However, there is evidence that retinoids might enhance tumo...
Autores principales: | Lenzi, Luana, Lee-Jones, Lisa, Mostofa, Maruf A., de Andrade, Diancarlos P., Ribeiro, Raul C., Figueiredo, Bonald C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761603/ https://www.ncbi.nlm.nih.gov/pubmed/33287098 http://dx.doi.org/10.3390/cancers12123610 |
Ejemplares similares
-
The Impact of Flt3 Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
por: Picharski, Gledson L., et al.
Publicado: (2019) -
Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020) -
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
por: Madan, V, et al.
Publicado: (2016) -
Acute promyelocytic leukemia presenting as an extradural mass
por: Bittencourt, Henrique, et al.
Publicado: (2011) -
History of Acute Promyelocytic Leukemia
por: Sanz, Miguel A., et al.
Publicado: (2021)